A perspective on how the United States fell behind Northern Europe in the battle against methicillin-resistant Staphylococcus aureus.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Private patient rooms and hospital-acquired methicillin-resistant Staphylococcus aureus: A hospital-level analysis of administrative data from the United States.PloS one · 2020
   Article
2. Control ofAntimicrobial resistance and infection control · 2019
   Article
3. A Perspective on the Principles of Integrity in Infectious Disease Research.Journal of patient safety · 2016
   Article
4. Nonimpact of Decolonization as an Adjunctive Measure to Contact Precautions for the Control of Methicillin-Resistant Staphylococcus aureus Transmission in Acute Care.Antimicrobial agents and chemotherapy · 2016
   Observational
5. Viewpoint: a response to "Screening and isolation to control methicillin-resistant Staphylococcus aureus: sense, nonsense, and evidence".Antimicrobial resistance and infection control · 2015
   Article
6. Planned Analyses of the REDUCE MRSA Trial.Antimicrobial agents and chemotherapy · 2014
   Article
7. The use of surveillance and preventative measures for methicillin-resistant staphylococcus aureus infections in surgical patients.Antimicrobial resistance and infection control · 2014
   Review
8. Reply to "Planned analyses of the REDUCE MRSA Trial".Antimicrobial agents and chemotherapy · 2014
   Article

Corrections and comments

• Commented on by
  Planned Analyses of the REDUCE MRSA Trial.2014
• Commented on by
  Reply to "Planned analyses of the REDUCE MRSA Trial".2014
• Erratum issued
  Erratum for Kavanagh et al., A Perspective on How the United States Fell behind Northern Europe in the Battle against Methicillin-Resistant Staphylococcus aureus.2016

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as